362 related articles for article (PubMed ID: 25916654)
1. ERBB4 is over-expressed in human colon cancer and enhances cellular transformation.
Williams CS; Bernard JK; Demory Beckler M; Almohazey D; Washington MK; Smith JJ; Frey MR
Carcinogenesis; 2015 Jul; 36(7):710-8. PubMed ID: 25916654
[TBL] [Abstract][Full Text] [Related]
2. ErbB4 promotes malignant peripheral nerve sheath tumor pathogenesis via Ras-independent mechanisms.
Longo JF; Brosius SN; Black L; Worley SH; Wilson RC; Roth KA; Carroll SL
Cell Commun Signal; 2019 Jul; 17(1):74. PubMed ID: 31291965
[TBL] [Abstract][Full Text] [Related]
3. OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal Tumors.
Ye GD; Sun GB; Jiao P; Chen C; Liu QF; Huang XL; Zhang R; Cai WY; Li SN; Wu JF; Liu YJ; Wu RS; Xie YY; Chan EC; Liou YC; Li BA
Gastroenterology; 2016 Mar; 150(3):659-671.e16. PubMed ID: 26619963
[TBL] [Abstract][Full Text] [Related]
4. Elevated Coexpression of KITENIN and the ErbB4 CYT-2 Isoform Promotes the Transition from Colon Adenoma to Carcinoma Following APC loss.
Bae JA; Kho DH; Sun EG; Ko YS; Yoon S; Lee KH; Ahn KY; Lee JH; Joo YE; Chung IJ; Lee SH; Kim H; Kim KK
Clin Cancer Res; 2016 Mar; 22(5):1284-94. PubMed ID: 26527747
[TBL] [Abstract][Full Text] [Related]
5. ErbB4 promotes cyclooxygenase-2 expression and cell survival in colon epithelial cells.
Frey MR; Hilliard VC; Mullane MT; Polk DB
Lab Invest; 2010 Oct; 90(10):1415-24. PubMed ID: 20585313
[TBL] [Abstract][Full Text] [Related]
6. The ErbB4 growth factor receptor is required for colon epithelial cell survival in the presence of TNF.
Frey MR; Edelblum KL; Mullane MT; Liang D; Polk DB
Gastroenterology; 2009 Jan; 136(1):217-26. PubMed ID: 18973758
[TBL] [Abstract][Full Text] [Related]
7. KITENIN functions as a fine regulator of ErbB4 expression level in colorectal cancer via protection of ErbB4 from E3-ligase Nrdp1-mediated degradation.
Sun EG; Lee KH; Ko YS; Choi HJ; Yang JI; Lee JH; Chung IJ; Paek YW; Kim H; Bae JA; Kim KK
Mol Carcinog; 2017 Mar; 56(3):1068-1081. PubMed ID: 27648936
[TBL] [Abstract][Full Text] [Related]
8. ERBB4 promotes the proliferation of gastric cancer cells via the PI3K/Akt signaling pathway.
Xu J; Gong L; Qian Z; Song G; Liu J
Oncol Rep; 2018 Jun; 39(6):2892-2898. PubMed ID: 29620274
[TBL] [Abstract][Full Text] [Related]
9. microRNA-7 is a novel inhibitor of YY1 contributing to colorectal tumorigenesis.
Zhang N; Li X; Wu CW; Dong Y; Cai M; Mok MT; Wang H; Chen J; Ng SS; Chen M; Sung JJ; Yu J
Oncogene; 2013 Oct; 32(42):5078-88. PubMed ID: 23208495
[TBL] [Abstract][Full Text] [Related]
10. Neuregulin-4 is a survival factor for colon epithelial cells both in culture and in vivo.
Bernard JK; McCann SP; Bhardwaj V; Washington MK; Frey MR
J Biol Chem; 2012 Nov; 287(47):39850-8. PubMed ID: 23033483
[TBL] [Abstract][Full Text] [Related]
11. WDR76 degrades RAS and suppresses cancer stem cell activation in colorectal cancer.
Ro EJ; Cho YH; Jeong WJ; Park JC; Min DS; Choi KY
Cell Commun Signal; 2019 Jul; 17(1):88. PubMed ID: 31362761
[TBL] [Abstract][Full Text] [Related]
12. Resistance to dual blockade of the kinases PI3K and mTOR in KRAS-mutant colorectal cancer models results in combined sensitivity to inhibition of the receptor tyrosine kinase EGFR.
Belmont PJ; Jiang P; McKee TD; Xie T; Isaacson J; Baryla NE; Roper J; Sinnamon MJ; Lee NV; Kan JL; Guicherit O; Wouters BG; O'Brien CA; Shields D; Olson P; VanArsdale T; Weinrich SL; Rejto P; Christensen JG; Fantin VR; Hung KE; Martin ES
Sci Signal; 2014 Nov; 7(351):ra107. PubMed ID: 25389372
[TBL] [Abstract][Full Text] [Related]
13. The deoxycholic acid targets miRNA-dependent CAC1 gene expression in multidrug resistance of human colorectal cancer.
Kong Y; Bai PS; Sun H; Nan KJ; Chen NZ; Qi XG
Int J Biochem Cell Biol; 2012 Dec; 44(12):2321-32. PubMed ID: 22903020
[TBL] [Abstract][Full Text] [Related]
14. Nuclear Softness Promotes the Metastatic Potential of Large-Nucleated Colorectal Cancer Cells via the ErbB4-Akt1-Lamin A/C Signaling Pathway.
Li Y; Li Q; Mu L; Hu Y; Yan C; Zhao H; Mi Y; Li X; Tao D; Qin J
Int J Biol Sci; 2024; 20(7):2748-2762. PubMed ID: 38725859
[TBL] [Abstract][Full Text] [Related]
15. ITF2 prevents activation of the β-catenin-TCF4 complex in colon cancer cells and levels decrease with tumor progression.
Shin HW; Choi H; So D; Kim YI; Cho K; Chung HJ; Lee KH; Chun YS; Cho CH; Kang GH; Kim WH; Park JW
Gastroenterology; 2014 Aug; 147(2):430-442.e8. PubMed ID: 24846398
[TBL] [Abstract][Full Text] [Related]
16. NOB1 is essential for the survival of RKO colorectal cancer cells.
He XW; Feng T; Yin QL; Jian YW; Liu T
World J Gastroenterol; 2015 Jan; 21(3):868-77. PubMed ID: 25624720
[TBL] [Abstract][Full Text] [Related]
17. Neuregulin-activated ERBB4 induces the SREBP-2 cholesterol biosynthetic pathway and increases low-density lipoprotein uptake.
Haskins JW; Zhang S; Means RE; Kelleher JK; Cline GW; Canfrán-Duque A; Suárez Y; Stern DF
Sci Signal; 2015 Nov; 8(401):ra111. PubMed ID: 26535009
[TBL] [Abstract][Full Text] [Related]
18. Colorectal Carcinogenesis: Connecting K-RAS-Induced Transformation and CREB Activity In Vitro and In Vivo.
Steven A; Heiduk M; Recktenwald CV; Hiebl B; Wickenhauser C; Massa C; Seliger B
Mol Cancer Res; 2015 Aug; 13(8):1248-62. PubMed ID: 25934695
[TBL] [Abstract][Full Text] [Related]
19. Bone marrow-derived mesenchymal stem cells promote colorectal cancer progression through paracrine neuregulin 1/HER3 signalling.
De Boeck A; Pauwels P; Hensen K; Rummens JL; Westbroek W; Hendrix A; Maynard D; Denys H; Lambein K; Braems G; Gespach C; Bracke M; De Wever O
Gut; 2013 Apr; 62(4):550-60. PubMed ID: 22535374
[TBL] [Abstract][Full Text] [Related]
20. High expression of protein phosphatase 4 is associated with the aggressive malignant behavior of colorectal carcinoma.
Li X; Liang L; Huang L; Ma X; Li D; Cai S
Mol Cancer; 2015 Apr; 14():95. PubMed ID: 25927939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
